Trans-3-((tert-Butyldimethylsilyl)oxy)cyclobutanol is a functionalized cyclobutane derivative featuring both a silyl-protected hydroxyl group and a free hydroxyl group on a four-membered ring. This specific stereochemistry (trans) and the presence of orthogonal protecting groups make it a valuable and versatile building block in synthetic organic chemistry. Its primary application is as a key chiral intermediate in the synthesis of complex pharmaceutical compounds. The molecule serves as a core scaffold for constructing strained ring systems found in active pharmaceutical ingredients (APIs). The tert-butyldimethylsilyl (TBS) group acts as a robust protecting group for one alcohol, allowing for selective manipulation of the free hydroxyl group during multi-step synthesis. This compound is particularly useful in medicinal chemistry for exploring structure-activity relationships (SAR) around the cyclobutane ring. As a specialized synthon, it is not a commodity chemical but is employed in research and development settings for constructing novel drug candidates, especially those targeting kinases and other biological pathways where the rigid, three-dimensional geometry of cyclobutane can impart desired pharmacological properties.